Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-040188
Filing Date
2025-04-28
Accepted
2025-04-28 16:06:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm252430d3_defa14a.htm DEFA14A 26649
2 GRAPHIC tm252430d3_defa14a-img01.jpg GRAPHIC 3208
3 GRAPHIC tm252430d3_defa14a-img02.jpg GRAPHIC 6573
4 GRAPHIC tm252430d3_defa14a-img03.jpg GRAPHIC 6860
5 GRAPHIC tm252430d3_defa14a-img04.jpg GRAPHIC 5496
6 GRAPHIC tm252430d3_defa14a-img05.jpg GRAPHIC 2269
  Complete submission text file 0001104659-25-040188.txt   62249
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 25880289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)